I obtained PhD under supervision of Professor Alexander T. Florence at the School of Pharmacy, University of London in 2008. After my PhD I joined the National Heart and Lung Institute, UK in 2008 to develop engineered nanomaterials for pulmonary drug delivery. In 2011, I developed nanomaterials for pulmonary drug targeting and nanotheranostic materials for cancer diagnostic and targeting drug delivery at Department of materials & London Centre for Nanotechnology, Faculty of Engineering, Imperial College London together with the Hamlyn Centre for Robotic Surgery, Department of Surgery and Cancer at Imperial College London. I join Mahidol university in 2017 where my research has been focused on nanomedicines, nanotheranostics, high content drug screening and regenerative medicines. I designed novel targeted nanotheranostics for cancer diagnostic and treatment. I develop biotherapeutics, phytochemical-based nanomaterials and products for biomedical application, drug and healthcare products. I am also a director of Centre of Molecular Targeting and Integrated Drug Development (CMT-IDD) where several hit compounds can be automatedly high content screening for their potential therapeutic activities.